NCT07623746

Brief Summary

Deciding what to do when for how long - self-organizing one's behaviour - is an important feature of daily life. Emotions arise providing short-cuts for the computational complexities. Yet, one still knows relatively little about the underlying cognitive and neural mechanisms. EMOBB will establish the computational, cognitive and neural underpinnings of the rich interplay between emotions and self-organized behaviour in naturalistic environments. Previous work has almost exclusively relied on tasks structured into experimenter determined trials - thus how people self-organized behaviour could not be measured. To overcome this, EMOBB will combine novel naturalistic tasks in which people have freedom what to do when for how long with subjective and objective measurements of emotions. This will be made possible through a computational modelling approach that allows dissecting and quantifying even complex behaviour-emotion interactions. Specifically, EMOBB will use three cognitive tasks of emotion-behaviour interplay that participants will do while undergoing functional magnetic resonance brain imaging and monitoring of their facial expressions with an MRI-compatible camera. The primary hypothesis of EMOBB is that both unique and shared neural networks will underpin the interplay between emotions and behaviour across our cognitive tasks.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
49mo left

Started Oct 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 20, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 3, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

9 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2030

Last Updated

June 3, 2026

Status Verified

May 1, 2026

Enrollment Period

4 years

First QC Date

May 20, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

FMRIEmotionsCognition

Outcome Measures

Primary Outcomes (1)

  • Brain activity in regions of interest

    Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) signal with FMRI compared to baseline across tasks across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).

    Day 0

Secondary Outcomes (3)

  • Brain activity during task 1 (Self-organization under threat)

    Day 0

  • Brain activity during task 2 (Self-organization and learning)

    Day 0

  • Brain activity during task 3 (Self-organization and social context)

    Day 0

Study Arms (3)

Task 1: self-organization under threat

EXPERIMENTAL
Other: Functional Magnetic Resonance Imaging (fMRI)

Task 2: self-organization and learning

EXPERIMENTAL
Other: Functional Magnetic Resonance Imaging (fMRI)

Task 3 : self-organization and social context

EXPERIMENTAL
Other: Functional Magnetic Resonance Imaging (fMRI)

Interventions

Participants will perform a cognitive task (responses through button presses) while we measure brain activity with functional magnetic resonance imaging (fMRI) and record their facial expressions.

Task 1: self-organization under threatTask 2: self-organization and learningTask 3 : self-organization and social context

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years old,
  • fluent French speakers,
  • healthy,
  • without a beard at the time of testing,
  • right-handed,
  • being able to use both hands
  • BMI between 18.5 and 30
  • give written informed consen
  • for women: contraception;

You may not qualify if:

  • neurological, psychiatric disorders, or severe chronic disorders (diabetes, cardiac, kidney, lung, liver disorders, inflammatory disorders)
  • pregnancy or breast-feeding
  • under guardianship, currently admitted to a psychiatric hospital other than for research purposes)
  • not wanting to be informed of abnormalities detected during MRI scan,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CERMEP (Centre d'Etude de Recherche Multimodal et pluridisciplinaire en imagerie du vivant)

Bron, 69500, France

Location

Study Officials

  • Jacqueline SCHOLL, PhD

    Institut National de la Santé Et de la Recherche Médicale, France

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jacqueline SCHOLL, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2026

First Posted

June 3, 2026

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 10, 2030

Last Updated

June 3, 2026

Record last verified: 2026-05

Locations